ASACO: Automatic and Serial Analysis of CO-expression to discover gene modifiers with potential use in drug repurposing.
Cristina Moral-TurónGualberto Asencio-CortésFrancesc Rodriguez-DiazAlejandro RubioAlberto G NavarroAna M Brokate-LlanosAndrés GarzónManuel Jesús MuñozAntonio J Pérez-PulidoPublished in: Briefings in functional genomics (2024)
Massive gene expression analyses are widely used to find differentially expressed genes under specific conditions. The results of these experiments are often available in public databases that are undergoing a growth similar to that of molecular sequence databases in the past. This now allows novel secondary computational tools to emerge that use such information to gain new knowledge. If several genes have a similar expression profile across heterogeneous transcriptomics experiments, they could be functionally related. These associations are usually useful for the annotation of uncharacterized genes. In addition, the search for genes with opposite expression profiles is useful for finding negative regulators and proposing inhibitory compounds in drug repurposing projects. Here we present a new web application, Automatic and Serial Analysis of CO-expression (ASACO), which has the potential to discover positive and negative correlator genes to a given query gene, based on thousands of public transcriptomics experiments. In addition, examples of use are presented, comparing with previous contrasted knowledge. The results obtained propose ASACO as a useful tool to improve knowledge about genes associated with human diseases and noncoding genes. ASACO is available at http://www.bioinfocabd.upo.es/asaco/.
Keyphrases
- genome wide
- genome wide identification
- healthcare
- gene expression
- bioinformatics analysis
- dna methylation
- transcription factor
- poor prognosis
- single cell
- endothelial cells
- machine learning
- deep learning
- emergency department
- big data
- rna seq
- adverse drug
- binding protein
- quality improvement
- electronic health record
- drug induced